Matharu
Amol Matharu, Bedminster, NJ US
Patent application number | Description | Published |
---|---|---|
20110028526 | VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONS - The invention relates to melt granulation processes for preparing immediate release and sustained release pharmaceutical formulations comprising valsartan. | 02-03-2011 |
Amol S. Matharu, Bedminster, NJ US
Patent application number | Description | Published |
---|---|---|
20100209480 | GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS - The present invention relates to a pharmaceutical oral fixed dose combination comprising | 08-19-2010 |
Amol S. Matharu, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20130115253 | Sustained Release Suspension Preparation For Dextromethorphan - A stabilized pharmaceutical composition comprises a drug-resin complex wherein the resin has been treated with an alkaline material prior to the formation of the drug-resin complex. The drug-resin complex may further be impregnated with an alkalizing agent, L-methionine, an antioxidant agent, or a combination thereof, or be coated with a diffusion barrier. A method of preparation of the pharmaceutical composition is provided. | 05-09-2013 |
Amol Singh Matharu, Bedminster, NJ US
Patent application number | Description | Published |
---|---|---|
20110189286 | Pulsatile Release of Valsartan - The present invention provides gastroretentive pulsatile pharmaceutical delivery systems that improve the bioavailability of Valsartan wherein the medicament has improved solubility, improved residence time in the gastrointestinal tract and a pulsatile release profile. | 08-04-2011 |
Arnol Singh Matharu, Bedminster, NJ US
Patent application number | Description | Published |
---|---|---|
20100233253 | EXTENDED RELEASE GASTRO-RETENTIVE ORAL DRUG DELIVERY SYSTEM FOR VALSARTAN - An extended release gastro-retentive drug delivery system of Valsartan. The drug delivery system contains a release portion containing the Valsartan, a gastro-retentive portion for retaining the drug delivery system in the stomach and an optional secondary portion for delivering a secondary pulse of Valsartan. In another embodiment, there is provided a swellable unfolding membrane comprising Valsartan for sustained administration of Valsartan to the upper GI tract of a patient. | 09-16-2010 |
Balvinder Singh Matharu, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20080206303 | Prolonged Release Formulations Comprising Anastrozole - The present invention relates to slow release anastrozole formulations, more particularly to in situ gelling formulations comprising a polylactide polymer or poly(lactide-co-glycolide) co-polymer, in which anastrozole is incorporated. The invention also relates to methods of treatment using said formulations, particularly methods for the treatment of breast cancer, and processes for the preparation of said formulations. | 08-28-2008 |
20080248077 | Formulation - The present invention relates to slow release anastrozole formulations, more particularly to biodegradable polymers, typically a polylactide or poly(lactide-co-glycolide) co-polymer, in which anastrozole is incorporated, including microparticle formulations and monolithic implant formulations. The invention also relates to methods of treatment using said formulations, particularly methods for the treatment of breast cancer. | 10-09-2008 |
Daljit S. Matharu, Lawrence, US US
Patent application number | Description | Published |
---|---|---|
20150119411 | INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS - Described herein are compounds, pharmaceutical compositions and methods for treating a respiratory syncytial virus infection in a subject, or for inhibiting replication of respiratory syncytial virus. | 04-30-2015 |
Kamay Matharu, Ontario CA
Patent application number | Description | Published |
---|---|---|
20100089693 | Erector Scaffold Deck Fall Arrest Assembly - A system and method for a scaffold deck with a fall arrest assembly is disclosed. The fall arrest assembly comprises a deck structure ( | 04-15-2010 |
Kamay Matharu, Markham CA
Patent application number | Description | Published |
---|---|---|
20110214940 | DEVICE OF ASSISTANCE FOR A USER OF A LADDER - In a ladder assistance device, a cable pulled by a controlled driving apparatus is laid in a loop along the height of the ladder, the user being attached to the cable by a lanyard, a sensor element detecting movements along the ladder, a control element controlling the driving apparatus. A remote control activates or deactivates assistance and allows user weight input, the remote control remaining in the reach of the user and including a stop button deactivating assistance and two activation buttons for activation of assistance, one each for “up”/“down”. A memory stores sets of control values for assistance level(s) for each direction of movement, corresponding to at most two levels in the steady state of the assistance. The program of the control element allowing: the selection that corresponds to the user weight, the activation which is only obtained by the activation buttons of the remote control. | 09-08-2011 |
Kawal Matharu, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20150037315 | DIETARY SUPPLEMENT - The present invention relates to a dietary supplement and methods of use thereof. More particularly, the invention relates to a composition including a kiwifruit extract in combination with an amylase inhibitor and/or a bifunctional protease-amylase inhibitor, particularly, but not exclusively, for managing gut health or for the treatment or prevention of digestive dysfunction, gastrointestinal disorders or symptoms thereof. | 02-05-2015 |
Manmit Singh Matharu, Dartford, Kent GB
Patent application number | Description | Published |
---|---|---|
20150331258 | TTL ADJUSTABLE BINOCULAR LOUPES DEVICE - A through-the-lens (TTL) adjustable binocular loupes device ( | 11-19-2015 |
Navjeet Kaur Matharu, Torfaen GB
Patent application number | Description | Published |
---|---|---|
20120172451 | CLEANING LIQUID - The present invention relates to a cleaning fluid, in particular a cleaning fluid for cleaning surfaces. | 07-05-2012 |
Rajinder Matharu, Bloomington, IN US
Patent application number | Description | Published |
---|---|---|
20090074721 | METHODS FOR TREATING VIRAL INFECTION WITH ORAL OR INJECTIBEL DRUG SOLUTION - Pharmaceutical composition comprising compounds and/or compositions useful to inhibit viral replication are disclosed. | 03-19-2009 |
20110034560 | LIQUID FORMULATIONS OF COMPOUNDS ACTIVE AT SULFONYLUREA RECEPTORS - The invention provides liquid formulations of compounds that act at sulfonylurea receptors that are suitable for intra-venous and intra-arterial infusion. Compounds active at a sulfonylurea receptor include glibenclamide, tolbutamide, repaglinide, nateglinide, meglitinide, midaglizole, LY397364, LY389382, glyclazide, and glimepiride. Liquid formulations may be concentrated solutions suitable for storage; may be diluted (e.g., dilution of 1:1 or 1:1.2) suitable for bolus injections, and may be further diluted (e.g., dilution of 1:10 or 1:20 or more) for intravenous and intra-arterial infusion over an extended period of time. For example, a liquid formulation may include at least about 0.05 mg/ml glibenclamide in a water-based solution including 40% polyethylene glycol 300, 10% Ethanol, 50% water, at about pH 9. The solution may include a buffer, and is suitable for storage in refrigerator or at room temperature. This solution may be diluted 1:1, or more (e.g., 1:20) without precipitation of the glibenclamide. | 02-10-2011 |
Saroop Matharu, Devens, MA US
Patent application number | Description | Published |
---|---|---|
20140045876 | PROCESS - The present invention provides a process for preparing an oxycodone acid adduct, said process comprising hydrogenating an aqueous solution of 14-hydroxycodeinone and an acid to form a solution of the oxycodone acid adduct, wherein the hydrogenation is carried out at one or more temperatures greater than ambient temperature in the presence of a hydrogenation catalyst and hydrogen gas, wherein the solution of oxycodone acid adduct comprises 6α-oxycodol in an amount ≦about 0.800 area % as determined by HPLC. | 02-13-2014 |
20150038715 | PROCESS - The present invention provides a process for preparing an oxymorphone acid adduct, said process comprising hydrogenating an aqueous solution of 14-hydroxymorphinone and an acid to form a solution of the oxymorphone acid adduct, wherein the hydrogenation is carried out at one or more temperatures greater than 40° C. in the presence of a hydrogenation catalyst and hydrogen gas, wherein the level of 6α-oxymorphol produced is ≦3.00 area % as determined by HPLC. | 02-05-2015 |
20150329553 | Process for the preparation of oxymorphone alkaloid and oxymorphone salts - The present invention provides a process for preparing an oxymorphone acid adduct, said process comprising hydrogenating an aqueous solution of 14-hydroxymorphinone and an acid to form a solution of the oxymorphone acid adduct, wherein the hydrogenation is carried out at one or more temperatures greater than 40° C. in the presence of a hydrogenation catalyst and hydrogen gas, wherein the level of 6α-oxymorphol produced is ≦3.00 area % as determined by HPLC. | 11-19-2015 |
Saroop Singh Matharu, Cricklade GB
Patent application number | Description | Published |
---|---|---|
20110178069 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME - The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-γ-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-γ-mediated diseases and decreasing IGIF and IFN-γ production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds. | 07-21-2011 |
20120165319 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME - The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-γ-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-γ-mediated diseases and decreasing IGIF and IFN-γ production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds. | 06-28-2012 |
Saroop Singh Matharu, Shirley, MA US
Patent application number | Description | Published |
---|---|---|
20110092596 | POLYMORPHS OF BROMFENAC SODIUM AND METHODS FOR PREPARING BROMFENAC SODIUM POLYMORPHS - Different polymorphs of bromfenac sodium may be prepared and interconverted using crystallization/recrystallization, drying and/or hydration techniques. | 04-21-2011 |
20130023588 | POLYMORPHS OF BROMFENAC SODIUM AND METHODS FOR PREPARING BROMFENAC SODIUM POLYMORPHS - Different polymorphs of bromfenac sodium may be prepared and interconverted using crystallization/recrystallization, drying and/or hydration techniques. | 01-24-2013 |
20130289120 | POLYMORPHS OF BROMFENAC SODIUM AND METHODS FOR PREPARING BROMFENAC SODIUM POLYMORPHS - Different polymorphs of bromfenac sodium may be prepared and interconverted using crystallization/recrystallization, drying and/or hydration techniques. | 10-31-2013 |
20140011880 | POLYMORPHS OF BROMFENAC SODIUM AND METHODS FOR PREPARING BROMFENAC SODIUM POLYMORPHS - Different polymorphs of bromfenac sodium may be prepared and interconverted using crystallization/recrystallization, drying and/or hydration techniques. | 01-09-2014 |
20140018428 | POLYMORPHS OF BROMFENAC SODIUM AND METHODS FOR PREPARING BROMFENAC SODIUM POLYMORPHS - Different polymorphs of bromfenac sodium may be prepared and interconverted using crystallization/recrystallization, drying and/or hydration techniques. | 01-16-2014 |
20140275567 | PROCESS FOR PREPARING ALKYL ESTERS OF 4-(5-(BIS(2-HYDROXYETHYL)AMINO)-1-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)BUTYRIC ACID - An alkyl ester of 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butyric acid, such as ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate, is obtained by reacting an alkyl ester of 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butyric acid with 2-hydroxyacetaldehyde under reducing conditions. | 09-18-2014 |
20150252052 | PROCESSES FOR MAKING HYDROCODONE, HYDROMORPHONE AND THEIR DERIVATIVES - Improved processes for making hydrocodone and hydromorphone as well as their 8,14-dihydrothebaine and 8,14-dihydrooripavine derivatives and salts are disclosed. | 09-10-2015 |
20150274641 | METHODS FOR MAKING POLYMORPHS OF BROMFENAC SODIUM AND BROMFENAC SODIUM FORMULATIONS - Different polymorphs of bromfenac sodium may be prepared and interconverted using crystallization/recrystallization, drying and/or hydration techniques. | 10-01-2015 |
Tarlochan S. Matharu, San Ramon, CA US
Patent application number | Description | Published |
---|---|---|
20110113117 | Asynchronous Collection and Correlation of Trace and Communications Event Data - A transaction processing system that includes a communications bridge between clients and a transaction processing engine provides a way to correlate events associated with the communications bridge and events associated with the transaction processing engine. By passing a unique identification information with the transaction requests and response between the communications bridge and transaction processing engine and including the unique identification information in logging information created by each, a correlation utility may correlate logging information to create a more complete view of the events associated with a transaction, including end-to-end response times. | 05-12-2011 |